Looking back: Genomics in 2023
We take a look through our blog at some of the notable articles of 2023, including a quick look at what happened since then
Your attitude towards genomics: Which classic Christmas character are you?
We frame some perspectives on genomic testing through the lens of popular Christmas icons. A guest written long read by genetic counsellor Dr Jonathan Roberts
A newcomer's takeaways from the Genomics Healthcare Summit
E-learning designer Jakob Whitfield offers two personal takeaways from NHS England’s 2023 summit on genomics in healthcare
Casgevy – how it works
In this week’s article, we revisit Casgevy and explore its utility and application in healthcare
Casgevy – the first CRISPR therapy
The UK has approved a new type of gene therapy for the blood disorders sickle cell disease and beta-thalassaemia, a world-first using CRISPR technology
RNA in spotlight as RNA research pioneers to be awarded Nobel prize
Two RNA researchers whose work paved the way for Covid-19 RNA vaccines will be awarded the 2023 Nobel Prize
Polygenic risk scores and DTC testing: a problematic pairing?
We explore polygenic risk scores and why their application in at-home genomic testing has been brought into question
Eight things a genetic counsellor may already be doing in your clinic
For today’s #GCAwarenessDay2023, NHS genetic counsellor Lily Barnett explains what you may see from this increasingly important and specialised profession
Gene therapy – a new approach for paediatric hearing loss
A new gene therapy is being trialled for children with a rare form of deafness caused by variants in the OTOF gene
The key principles behind newborn genome screening
The Generation Study will explore the benefits and challenges of sequencing the genomes of 100,000 newborn babies
Genomics England to launch the Generation Study
This winter sees the start of the Generation Study, which will explore the benefits and challenges of sequencing the genomes of 100,000 newborns
Mainstreaming whole genome sequencing: where are we now?
Genomic testing capabilities are advancing in affordability and accessibility by the day. But what is the current trajectory of whole genome sequencing in healthcare?